Correction: Application of RhBMP-2 in Percutaneous Endoscopic Posterior Lumbar Interbody Fusion.
作者信息
Chen Yunsheng, Xu Canhua, Wu Yaohong, Shi Jiangyou, Chen Rongchun
机构信息
Department of Spinal Surgery, Ganzhou People's Hospital, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China.
出版信息
BMC Surg. 2025 Jan 10;25(1):16. doi: 10.1186/s12893-024-02732-5.
Abstract
摘要
相似文献
1
Correction: Application of RhBMP-2 in Percutaneous Endoscopic Posterior Lumbar Interbody Fusion.
BMC Surg. 2025 Jan 10;25(1):16. doi: 10.1186/s12893-024-02732-5.
2
Application of RhBMP-2 in Percutaneous Endoscopic Posterior Lumbar Interbody Fusion.
BMC Surg. 2024 Nov 26;24(1):376. doi: 10.1186/s12893-024-02674-y.
3
Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Spine J. 2004 Sep-Oct;4(5):527-38; discussion 538-9. doi: 10.1016/j.spinee.2004.03.025.
4
[Current status and progress of minimally invasive percutaneous endoscopic lumbar interbody fusion].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Jun 15;36(6):660-664. doi: 10.7507/1002-1892.202203002.
5
Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Spine J. 2007 May-Jun;7(3):301-7. doi: 10.1016/j.spinee.2006.10.015. Epub 2007 Jan 2.
6
rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) in real world spine surgery. A phase IV, National, multicentre, retrospective study collecting data from patient medical files in French spinal centres.
Orthop Traumatol Surg Res. 2019 Oct;105(6):1157-1163. doi: 10.1016/j.otsr.2019.04.023. Epub 2019 Jul 16.
7
Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
Spine (Phila Pa 1976). 2013 Dec 15;38(26):2264-71. doi: 10.1097/BRS.0000000000000045.
8
[Analysis of technical advantages and disadvantages of percutaneous endoscopic lumbar interbody fusion and its trend prospect].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Jun 15;36(6):653-659. doi: 10.7507/1002-1892.202202075.
9
The Combined Effects of RhBMP-2 and Systemic RANKL Inhibitor in Patients With Bone Density Loss Undergoing Posterior Lumbar Interbody Fusion: A Retrospective Observational Analysis With Propensity Score Matching.
Neurospine. 2023 Dec;20(4):1186-1192. doi: 10.14245/ns.2346702.351. Epub 2023 Dec 31.
10
Clinical efficacy of percutaneous endoscopic posterior lumbar interbody fusion and modified posterior lumbar interbody fusion in the treatment of lumbar degenerative disease.
J Orthop Surg Res. 2024 Jan 16;19(1):70. doi: 10.1186/s13018-024-04544-y.
本文引用的文献
1
Application of RhBMP-2 in Percutaneous Endoscopic Posterior Lumbar Interbody Fusion.
BMC Surg. 2024 Nov 26;24(1):376. doi: 10.1186/s12893-024-02674-y.
Zotero 插件